Manufacturer record
Medley Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Medley Pharmaceuticals Ltd (Daman & Diu) were declared Not of Standard Quality between March 2023 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Medley Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin & Ornidazole Tablets IP | E50058Mfg 2025-01 · Exp 2028-12 | The sample does not conform to I.P. w.r.to the tests for Dissolution And AssayAssay | SDTL, AssamState lab | Apr 2026 |
| Haematinic Capsules (R.B. TONE) | D40652Mfg 2024-11 · Exp 2026-10 | Microbial limit test (Total combined yeasts/molds count)Microbial limits | CDTL-MumbaiCDSCO lab | May 2025 |
| Pioglitazone Hydrochloride Tablets (GLITO 15) | D40292Mfg 2024-05 · Exp 2027-04 | "Dissolution"Dissolution | CDTL MumbaiCDSCO lab | Apr 2025 |
| Ofloxacin & Ornidazole Tablets I.P. (O2) | E20512Mfg 2022-04 · Exp 2025-03 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2023 |
| O2 (Ofloxacin & Ornidazole Tablets I.P.) | E20034Mfg 2022-01 · Exp 2024-12 | Identification and Assay of Ofloxacin & OrnidazoleAssay | RDTL GuwahatiState lab | Mar 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.